Institutions / Superstring Capital Management LP
Superstring Capital Management LP
CIK 1931118 · Institution · as of Dec 31, 2025
Portfolio value
$186.78M
Positions
45
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 45 →
| Company | Value | % of portfolio |
|---|---|---|
| Cidara Therapeutics Inc | $18.80M | 10.1% |
| Terns Pharmaceuticals, Inc. | $17.93M | 9.6% |
| Urogen Pharma Ltd | $16.82M | 9.0% |
| Cogent Biosciences, Inc. | $13.01M | 7.0% |
| Dynavax Technologies Corp | $8.08M | 4.3% |
| Sionna Therapeutics, Inc. | $7.43M | 4.0% |
| Immunovant, Inc.IMVT | $7.34M | 3.9% |
| Axsome Therapeutics, Inc. | $6.84M | 3.7% |
| Savara IncSVRA | $6.00M | 3.2% |
| Mind Medicine Mindmed Inc | $5.69M | 3.0% |
| Taysha Gene Therapies, Inc.TSHA | $5.39M | 2.9% |
| Ocular Therapeutix, Inc | $5.08M | 2.7% |
| Amicus Therapeutics Inc | $5.03M | 2.7% |
| Cabaletta Bio, Inc. | $4.94M | 2.6% |
| United Therapeutics Corp | $4.61M | 2.5% |
| Revolution Medicines, Inc. | $4.37M | 2.3% |
| Belite Bio, IncBLTE | $3.95M | 2.1% |
| Bright Minds Biosciences Inc. | $3.69M | 2.0% |
| Zai Lab Limited | $3.47M | 1.9% |
| Zenas BioPharma, Inc.ZBIO | $3.03M | 1.6% |
| Quince Therapeutics Inc | $2.88M | 1.5% |
| Avalo Therapeutics, Inc. | $2.78M | 1.5% |
| Capricor Therapeutics, Inc. | $2.78M | 1.5% |
| Palvella Therapeutics, Inc.PVLA | $2.67M | 1.4% |
| Celldex Therapeutics, Inc. | $2.40M | 1.3% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.